OMGA(Delisted)
Omega TherapeuticsยทNASDAQ
--
--(--)
OMGA fundamentals
Omega Therapeutics (OMGA) released its earnings on Sep 10, 2021: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Sep 10, 2021
EPS
Revenue
Revenue & Expenses
OMGA has released its 2024 Q3 earnings report, with revenue of 2.61M, reflecting a YoY change of 214.32%, and net profit of -16.44M, showing a YoY change of 26.09%. The Sankey diagram below clearly presents OMGA's revenue sources and cost distribution.
Key Indicators
Omega Therapeutics (OMGA) key financial stats and ratios, covering profitability, financial health, and leverage.
Omega Therapeutics (OMGA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Omega Therapeutics (OMGA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Omega Therapeutics (OMGA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Omega Therapeutics (OMGA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Omega Therapeutics (OMGA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
